FDA NDC Directory · JSON-LD · Markdown

RIDAURA

NDC 54766-093 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nameauranofin
Labeler / ManufacturerSebela Pharmaceuticals Inc.
Marketing categoryNew Drug Application (innovator) · App NDA018689
Dosage form / routeCAPSULE · ORAL
Active ingredientsAURANOFIN (3 mg/1)
Marketing started20161215
Marketing ended20271031
Package count1

External sources

Source: openFDA. Public-domain (CC0).